ETERNAL PROJECT | 6-month meeting

Collaborative project to boost reduction of the environmental impact of pharmaceutical products through their entire life cycle

Collaborative project to boost reduction of the environmental impact of pharmaceutical products through their entire life cycle
March 24, 2023

The ETERNAL project team has gathered together in Aveiro, Portugal, to hold its 6-month meeting. This four-year EC Horizon Europe Research and Innovation Action will contribute to sustainable development of pharmaceutical manufacture, use and disposal, by using and promoting full life cycle approaches covering design, manufacture, usage, and disposal, assessing the environmental risks of not only active pharmaceutical ingredients and residues or metabolites, but other chemicals and by-products of the production process. In other words, safe and sustainable pharmaceutical lifecycles by design.

Asphalion experts André Mota and Izabela Bedziak have attended the meeting. Asphalion is the regulatory partner throughout the project, providing regulatory guidance to support understanding of the environmental exposure and ecotoxicity during pharmaceuticals development to ensure the solutions are commercially deployable in the future through a compliant by design approach according to applicable regulatory guidelines and technical standards. Due to Asphalion expertise in the regulatory field, Asphalion will also engage with policy makers, regulators and standards bodies to ensure a regulatory framework that enables green innovation.

For further information, you can check the project´s homepage:

ETERNAL INFORMATION

You can also send us your info requests at: info@asphalion.com

This project has received funding from the European Union’s Horizon Europe Framework Programme (HORIZON) under grant agreement No 101057668.

Search News & Events

  • Filter by category

Share

Related news and events

NEW | User Acceptance Testing (UAT) phase

Asphalion Expert Beatriz Ugalde Dionicio has been selected by the European Medicines Agency (EMA) to participate in the Product Management Service (PMS) Product User Interface

NEW | CTIS EMA Subject Matter Expert

At Asphalion we are very proud to announce that Nuria Garcia Pazos has been appointed EMA Subject Matter Expert (SME) for Clinical Trials Information System

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting